Search for: "Watson Laboratories"
Results 161 - 180
of 250
Sort by Relevance
|
Sort by Date
13 Jan 2011, 2:52 pm
The 111th Congress turned out to be a very productive session that ushered in several major policy reforms for animal welfare that were top priorities for HSUS and HSLF. [read post]
12 Jan 2011, 10:55 am
The reliability of forensic DNA testing results might be questioned for any number of reasons, e.g., laboratory error, cross-contamination, interpretive bias or fraud, etc. [read post]
22 Dec 2010, 3:01 am
Watson Laboratories, Inc. [read post]
12 Dec 2010, 9:47 pm
Hunt • Defendants: IMPAX Laboratories, Inc.; Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc. [read post]
10 Dec 2010, 2:31 pm
Watson Laboratories, Inc., C.A. [read post]
8 Dec 2010, 6:07 pm
Other GnRH drugs include Watson Pharmaceuticals Inc's Trelstar and Endo Pharmaceuticals Holdings Inc's Vantas. [read post]
17 Nov 2010, 1:48 am
PhotoCure (FDA Law Blog) US: Clinical trial requirements are top issue at FDA hearings on biosimilars (Patent Docs) Products Allegra (Fenofexadine, Psuedoephedrine) – US: Impax Laboratories receives final FDA approval for generic Allegra-D 60mg/120mg tablets (SmartBrief) Allegra (Fexofenadine) – US: Sanofi-Aventis, Aventisub, Carderm file patent infringement complaint against Aurolife, Aurobindo following Para IV certification (Patent Docs) Boniva (Ibandronate) – US: Roche… [read post]
14 Nov 2010, 8:48 pm
Watson Pharmaceuticals, Inc. et al. 2:10-cv-01969; filed November 11, 2010 in the District Court of Nevada • Plaintiffs: Astrazeneca UK Ltd.; IPR Pharmaceuticals, Inc.; Shionogi Seiyaku Kabushiki Kaisha • Defendants: Watson Pharmaceuticals, Inc.; Watson Pharma, Inc.; Watson Laboratories, Inc. [read post]
10 Nov 2010, 1:11 am
Highlights this week included: US government intervenes in patentability of genes – AMP v USPTO (Patent Baristas) (Holman’s Biotech IP Blog) (Intellectual Property Law Blog) (Inovia) (BlawgIT) (IP Osgoode) Temodar (Temozolomide) – US: CAFC limits prosecution laches defense: Cancer Research Technology v Barr Laboratories (Inventive Step) (IPBiz) (Patently-O) (SmartBrief) Italian antitrust authority opens preliminary investigation into whether Pfizer subsidiary artificially… [read post]
12 Oct 2010, 8:56 pm
(FDA Law Blog) Lyrica (Pregabalin) – US: Pfizer files patent infringement suit against Lupin in response to Para IV certification filing (Patent Docs) Opana (Oxymorphone) – US: Watson reaches settlement with Endo over Opana ER (SmartBrief) OsmoPrep (Sodium biphosphate, Sodium phosphate) – US: Salix Pharma and Novel Labs settle OsmoPrep patent litigation (Patent Docs) Sanctura XR (Trospium) – US: Allergan file patent infringement complaints against Paddock… [read post]
27 Sep 2010, 12:59 am
District Court for the District of Columbia challenging FDA’s September 14th approval of Watson Laboratories, Inc. [read post]
23 Sep 2010, 9:20 pm
Before the District Court reached the infringement issue, Solvay, Watson, and... [read post]
23 Sep 2010, 12:39 pm
District Court for the District of Columbia challenging FDA’s September 14th approval of Watson Laboratories, Inc. [read post]
15 Sep 2010, 2:40 am
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP) US: PHOSITA:… [read post]
25 Aug 2010, 12:37 am
Watson Pharma, Inc. et al. [read post]
5 Aug 2010, 2:08 pm
Wyeth Laboratories, Inc., 533 N.E.2d 748 (Ohio 1988) (the Ohio Supreme Court rejecting the theory). [read post]
28 Jul 2010, 12:06 am
Watson Laboratories, Inc. [read post]
27 Jul 2010, 7:18 pm
Magistrate Judge on July 13 ruled that the president and CEO of Watson Pharmaceuticals made a “colorable claim that the FTC may have exceeded its authority by using its investigative power to pressure Watson to enter into a business deal that the FTC considers desirable. [read post]
27 Jun 2010, 10:37 pm
It targets the companies Pliva Pharmaceuticals, Barr Laboratories, Teva Pharmaceuticals and Watson Pharmaceuticals — all are generic manufacturers of Reglan. [read post]
8 Jun 2010, 8:14 am
Watson Laboratories, Inc., No. 1:2010cv01323 (filed May 24, 2010); this Hatch-Waxman patent infringement lawsuit was brought by Genzyme after Watson sought Food and Drug Administration (FDA) approval to market in the US a generic version of the company's Renvela(R) drug product (sevelamer carbonate). [read post]
